Magnerot (Magnesium Orotate Dihydrate)

Magnesium orotate dihydrate provides magnesium ions that act as cofactors for many enzymatic reactions, including those involved in ATP production, protein synthesis, and ion transport. These ions help stabilize cell membranes, regulate calcium channels, and support neuromuscular and cardiac function.

The appropriate dose of Magnerot is determined by a qualified prescriber based on the individual’s clinical condition, laboratory values, and overall health status. Patients should follow the dosing instructions provided by their healthcare professional.

The safety of Magnerot in pregnancy and lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this product.

To order Magnerot, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Magnerot delivers magnesium as the orotate salt, which may offer enhanced cellular uptake compared with inorganic salts such as magnesium oxide. While clinical differences are modest, some clinicians prefer orotate for its potential cardioprotective properties, whereas other magnesium forms are chosen for cost or specific gastrointestinal tolerance.

Magnerot should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.

Magnerot is taken orally, usually with water. It can be taken with or without food, but patients should follow the prescriber’s guidance regarding timing relative to meals or other medications to optimize absorption.

The most serious risks include hypermagnesemia, which can cause cardiac arrhythmias, severe hypotension, respiratory depression, and in rare cases, allergic reactions such as rash or swelling. Patients with renal impairment are at higher risk and should be monitored closely.

Magnerot should be avoided in individuals with known hypersensitivity to magnesium orotate, those with severe renal failure, existing hypermagnesemia, or significant heart block without medical supervision. Consultation with a healthcare professional is essential before initiating therapy.